Yael Cohen is Senior Vice President, Head of Clinical Operations at Prilenia. Yael is a clinical research professional with more than 25 years of experience in the pharmaceutical industry, leading all aspects of Phase 1, 2, and 3 complex registrational clinical studies of drugs, devices, and drug-device combinations in a global environment. Yael has a wide range of expertise across various indications, mainly in CNS.

Yael previously served as Director of Global Clinical Operations at NeuroDerm Ltd. For 4 years she was responsible for the operational execution of global development programs in Parkinson’s disease, which included oversight of 5 clinical studies in parallel, Phase 1, 2, and 3, including responsibility for a budget of several millions of dollars. From 2004 to 2014, Yael held positions of increasing responsibility in clinical operations at several Israeli start-up companies, including 3 years of relocation in the United States, managing the registrational study of Evolence.

Previously, Yael served as Senior Clinical Research Associate at Bristol Myers Squibb, a global pharmaceutical company. She received both her BSc. in pharmacy and MSc in clinical pharmacy from the School of Pharmacy at the Hebrew University of Jerusalem.

• 

  SVP, Head of Clinical Operations in Prilenia

  Pursuing Hope. Leading With Science.